Product Information
BICALUTAMIDE 50 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.4028 per EA under NDC 00904601946. Its NADAC has been published 645 times since Nov 28, 2013.
FDA first approved this application on Jul 6, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904601946
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
3/18/2026
Active Ingredients
BICALUTAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078917FDA Approved
7/6/2009
TE Code
AB
On Market Since
5/11/2010
Pharmacological Classes
Price Statistics
The NADAC for BICALUTAMIDE 50 MG TABLET has been published 645 times since Nov 28, 2013, and over the history we have for it it has declined 10.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4028 per EA |
|---|---|
| All-time high | $0.4740 (Feb 12, 2014) |
| All-time low | $0.2354 (Feb 20, 2019) |
| 52-week high | $0.4300 |
| 52-week low | $0.3953 |
| Median price | $0.3331 |
| Average price | $0.3412 |
| Largest weekly change | +50.2% (Jul 17, 2024) |
| Weeks tracked | 645 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
+0.5%
1Y
-6.3%
3Y
+23.9%
5Y
+15.3%
All
-10.9%
Last surveyed Apr 1, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BICALUTAMIDE 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BICALUTAMIDE 50 MG TABLET, manufactured by Major Pharmaceuticals, is $0.4028 per EA (NDC 00904601946), effective Apr 1, 2026.
How has the price of BICALUTAMIDE 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for BICALUTAMIDE 50 MG TABLET has declined 10.9%. It has been tracked across 645 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BICALUTAMIDE 50 MG TABLET?
Since Nov 28, 2013, the NADAC for BICALUTAMIDE 50 MG TABLET has ranged from a low of $0.2354 (Feb 20, 2019) to a high of $0.4740 (Feb 12, 2014), with a median of $0.3331 per EA.
Are there cheaper alternatives to BICALUTAMIDE 50 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BICALUTAMIDE 50 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures BICALUTAMIDE 50 MG TABLET?
BICALUTAMIDE 50 MG TABLET (NDC 00904601946) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.